SEC Form 3/A · accession 0001209191-17-004484
Dare Bioscience, Inc. · DARE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 3/A). It replaces an earlier filing for the same period.
Reporting owner
Scott Eliasof
Officer — SVP, Chief Scientific Officer
Period of report
Oct 25, 2016
Accepted (ET)
Jan 19, 2017 · 4:31 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001401914
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | holding | — | — | — | 100 | I | By Tapscott-Eliasof 2012 Family Trust |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1These shares were omitted from the reporting person's original Form 3.